What AI says about BioSkryb Genomics

BioSkryb Genomics provides an integrated single-cell multiomics platform that simultaneously analyzes the genome, full-length transcriptome, and surface proteins from individual cells. The company’s patented PTA technology achieves 97% genome coverage, enabling researchers to uncover rare mutations and cell populations for applications in oncology, neurology, diagnostics, and AI-driven precision medicine.